ReWalk Robotics Ltd. has expressed its gratitude to Yohanan Engelhardt for his contributions as a director, as he is set to step down from the position. Engelhardt, who served on ReWalk’s Board of Directors for over five years, was the chairman of the audit committee and made significant contributions to the financial governance of the company.
Chairman of the Board of ReWalk, Jeff Dykan, acknowledged Engelhardt’s crucial role in the organization and highlighted his expertise in utilizing financial knowledge to benefit ReWalk. Dykan expressed his gratitude on behalf of the entire company and noted that Engelhardt will be missed.
ReWalk Robotics Ltd. is a medical device company that specializes in designing, developing, and commercializing innovative technologies. These technologies are aimed at improving mobility and wellness for individuals with neurological conditions, both in rehabilitation and daily life. The company’s mission is to fundamentally enhance the quality of life for these individuals through the creation and development of market-leading technologies.
Established in 2001, ReWalk operates in the United States, Israel, and Germany. The company has gained recognition for its ReWalk® and ReStore® systems, which aim to provide individuals with neurological conditions with the ability to restore mobility and regain independence.
It is important to note that the forward-looking statements in this press release are subject to uncertainty, risks, and changes in circumstances. ReWalk has acknowledged that it is difficult to predict these factors and many of them are beyond the company’s control. Interested parties are encouraged to refer to ReWalk’s periodic filings with the U.S. Securities and Exchange Commission (SEC) for a more comprehensive understanding of the risk factors associated with the company.
ReWalk Media Relations:
E: [email protected]
ReWalk Investor Contact:
Chief Financial Officer
ReWalk Robotics Ltd.
E: [email protected]
ReWalk Robotics Ltd. (source article)